Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Tax Provisions (2018 - 2025)

Historic Tax Provisions for Protagonist Therapeutics (PTGX) over the last 5 years, with Q2 2025 value amounting to $200000.0.

  • Protagonist Therapeutics' Tax Provisions rose 12857.14% to $200000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 72.53%. This contributed to the annual value of $4.2 million for FY2024, which is N/A changed from last year.
  • As of Q2 2025, Protagonist Therapeutics' Tax Provisions stood at $200000.0, which was up 12857.14% from $2.0 million recorded in Q4 2024.
  • Protagonist Therapeutics' Tax Provisions' 5-year high stood at $3.3 million during Q1 2024, with a 5-year trough of -$700000.0 in Q2 2024.